Cargando…
Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota
Toll-like receptor 2 (TLR2) expressed on myeloid cells mediates the recognition of harmful molecules belonging to invading pathogens or host damaged tissues, leading to inflammation. For this ability to activate immune responses, TLR2 has been considered a player in anti-cancer immunity. Therefore,...
Autores principales: | Di Lorenzo, Antonino, Bolli, Elisabetta, Tarone, Lidia, Cavallo, Federica, Conti, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763461/ https://www.ncbi.nlm.nih.gov/pubmed/33321934 http://dx.doi.org/10.3390/ijms21249418 |
Ejemplares similares
-
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy
por: Di Lorenzo, Antonino, et al.
Publicado: (2022) -
Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models
por: Barutello, Giuseppina, et al.
Publicado: (2022) -
Interaction between gut microbiota and toll-like receptor: from immunity to metabolism
por: Yiu, Jensen H.C., et al.
Publicado: (2016) -
Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial
por: Riccardo, Federica, et al.
Publicado: (2022) -
The Association Between Gut Microbiota, Toll-Like Receptors, and
Colorectal Cancer
por: Fang, Yongkun, et al.
Publicado: (2022)